Study to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal Disease
Clinical trial NCT02437422 · COMPLETED
Trial details
- NCT number
- NCT02437422
- Sponsor
- Prolong Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-05
- Primary completion
- 2015-11-18
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.